title: Pemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer.
abstract: BACKGROUND
  Molecular diagnosis has been proposed to enhance the intra-operative diagnosis of sentinel lymph node (SLN) invasion in head and neck squamous cell carcinoma (HNSCC). Although cytokeratin (CK) mRNA quantification with real-time reverse transcriptase-PCR (QRT-PCR) has produced encouraging results, the more discriminating markers remain to be identified.
  
  
  METHODS
  Pemphigus vulgaris antigen (PVA), squamous cell carcinoma antigen (SCCA), and CK17 mRNA were quantified using QRT-PCR, and the results were compared with an extensive histopathological examination of the entire SLNs on 78 SLNs harvested from 22 patients with HNSCC.
  
  
  RESULTS
  SCCA and CK17 quantification showed significantly higher mRNA values for macrometastases (MAs) than for either negative or isolated tumour cell (ITC) SLNs (P<0.01). Pemphigus vulgaris antigen allowed the discrimination of all MAs and micrometastases from both negative and ITC SLNs (P<0.001). For the neck staging of patients, considering metastatic vs non-metastatic status, receiver-operating characteristic curve analysis found areas under the curve of 93.8, 97.9, and 100% for CK17, SCCA, and PVA, respectively. With PVA, a cutoff value of 562 copies per 100 ng of cDNA permitted the correct distinction between patients with positive as opposed to negative neck nodes in all cases.
  
  
  CONCLUSIONS
  PVA seems to be a highly promising marker for accurate intra-operative SLN staging in HNSCC by QRT-PCR.
authors.affiliation: Cellular Biology Department, Montpellier Teaching Hospital, Montpellier, France.
authors.forename: J
authors.initials: J
authors.lastname: Solassol
authors.forename: V
authors.initials: V
authors.lastname: Burcia
authors.forename: V
authors.initials: V
authors.lastname: Costes
authors.forename: J
authors.initials: J
authors.lastname: Lacombe
authors.forename: A
authors.initials: A
authors.lastname: Mange
authors.forename: E
authors.initials: E
authors.lastname: Barbotte
authors.forename: D
authors.initials: D
authors.lastname: de Verbizier
authors.forename: C
authors.initials: C
authors.lastname: Cartier
authors.forename: M
authors.initials: M
authors.lastname: Makeieff
authors.forename: L
authors.initials: L
authors.lastname: Crampette
authors.forename: N
authors.initials: N
authors.lastname: Boulle
authors.forename: T
authors.initials: T
authors.lastname: Maudelonde
authors.forename: B
authors.initials: B
authors.lastname: Guerrier
authors.forename: R
authors.initials: R
authors.lastname: Garrel
mesh_terms: D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis*; D019540:Area Under Curve; D014408:Biomarkers, Tumor / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000276:immunology / Q000556:secondary*; D051184:Desmoglein 3 / Q000032:analysis*; D005260:Female; D006801:Humans; D053537:Keratin-17 / Q000032:analysis; D008207:Lymphatic Metastasis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging / Q000379:methods*; D009959:Oropharyngeal Neoplasms / Q000276:immunology / Q000473:pathology*; D011237:Predictive Value of Tests; D012333:RNA, Messenger / Q000032:analysis*; D012334:RNA, Neoplasm / Q000032:analysis*; D012372:ROC Curve; D011877:Radionuclide Imaging; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D021701:Sentinel Lymph Node Biopsy; D015843:Serpins / Q000032:analysis; D014062:Tongue Neoplasms / Q000276:immunology / Q000473:pathology*
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; C071894:DSG3 protein, human; D051184:Desmoglein 3; D053537:Keratin-17; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D015843:Serpins; C051072:squamous cell carcinoma-related antigen